Across much of the South and Midwest, the combination of high obesity prevalence, lower wages, and limited insurance coverage creates what could be described as GLP-1 deserts regions where access is constrained not just by price, but by insurance exclusions and state-level policy decisions
Including these allows for a more holistic view of your metabolic health, which we believe is essential for responsible monitoring, as explained in our Thyroid Tests with Cortisol and Magnesium
Do not use this for dosing decisions
GLP-1 receptor agonists like semaglutide and liraglutide work by regulating appetite and glucose metabolism, with no direct effect on spinal or musculoskeletal structures
, assistant professor of medicine at Columbia University Irving Medical Center and an adult endocrinologist at the Naomi Berrie Diabetes Center in NYC
Data are represented as number and percentage of patients